Cargando…
Corrections to “An Optimized Safe Process from Bench to Pilot cGMP Production of API Eptifibatide Using a Multigram-Scale Microwave-Assisted Solid-Phase Peptide Synthesizer”
Autores principales: | D’Ercole, Annunziata, Pacini, Lorenzo, Sabatino, Giuseppina, Zini, Matteo, Milli, Lorenzo, Nuti, Francesca, Ribecai, Arianna, Paio, Alfredo, Rovero, Paolo, Papini, Anna Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396654/ https://www.ncbi.nlm.nih.gov/pubmed/36037038 http://dx.doi.org/10.1021/acs.oprd.2c00224 |
Ejemplares similares
-
Porcine Relaxin but Not Serelaxin Shows Residual Bioactivity after In Vitro Simulated Intestinal Digestion—Clues for the Development of New Relaxin Peptide Agonists Suitable for Oral Delivery
por: Pacini, Lorenzo, et al.
Publicado: (2022) -
Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design
por: D'Ercole, Annunziata, et al.
Publicado: (2022) -
Multigram Synthesis
of Pure HMF and BHMF
por: Trapasso, Giacomo, et al.
Publicado: (2022) -
NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009) -
cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015)